BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $378,000 | -86.4% | 112,079 | -88.2% | 0.00% | -89.2% |
| Q4 2018 | $2,784,000 | -53.1% | 953,368 | -1.0% | 0.04% | -45.6% |
| Q3 2018 | $5,933,000 | -13.0% | 963,148 | +4.3% | 0.07% | -17.1% |
| Q2 2018 | $6,818,000 | +1141.9% | 923,824 | +1004.4% | 0.08% | +1071.4% |
| Q1 2018 | $549,000 | +45.6% | 83,649 | +174.0% | 0.01% | +16.7% |
| Q1 2017 | $377,000 | -9.4% | 30,525 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $416,000 | -31.5% | 30,525 | 0.0% | 0.01% | -33.3% |
| Q3 2016 | $607,000 | +36.1% | 30,525 | -11.3% | 0.01% | +28.6% |
| Q2 2016 | $446,000 | +42.9% | 34,417 | -3.2% | 0.01% | +40.0% |
| Q1 2016 | $312,000 | -39.4% | 35,569 | +40.1% | 0.01% | -28.6% |
| Q4 2015 | $515,000 | +39.9% | 25,394 | +0.4% | 0.01% | +40.0% |
| Q3 2015 | $368,000 | -31.6% | 25,304 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $538,000 | – | 25,304 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |